Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA

This page provides a comprehensive list of Manufacturing and Wholesale Distribution authorisations that have been suspended or revoked by the Medicines and Healthcare products Regulatory Agency (MHRA). These actions are taken to ensure public safety and maintain the integrity of the UK’s healthcare system.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
98 Entities in Suspended and Revoked Manufacturing and Wholesale Distribution Authorisations by MHRA
Entity NameEntity TypeEffective DateStatus

RELIABLE MEDICARE LIMITED

CompanyFeb 15, 2018active

WEBSTAR DIXON LIMITED

CompanyNov 4, 2020active

CHESTERFIELD PHARMA LIMITED

CompanyMar 21, 2022inactive

CHOPRAS PHARMACY LIMITED

CompanyNov 17, 2021active

Brookmed Limited

CompanyApr 18, 2023active

Brookmed Ltd

CompanyOct 12, 2022inactive

RIVERSIDE BOURNEMOUTH LIMITED

CompanyFeb 14, 2019active

LAUDON DISPENSING CHEMIST LIMITED

CompanyJul 23, 2014active

PHARMA CURE HEALTH CARE LIMITED

CompanyMay 7, 2014active

ELIXIR LONDON LIMITED

CompanyFeb 8, 2022inactive

FAQs

Why is compliance with Suspended Medicaid Providers by Nevada Department of Health and Human Services necessary?

It is crucial to comply with the list of Suspended Medicaid Providers published by the Nevada Department of Health and Human Services. This list identifies healthcare providers who are no longer allowed to participate in the medicaid program due to various issues, including fraud, misconduct, or failure to meet regulatory standards.

Which companies should comply with Suspended Medicaid Providers by Nevada Department of Health and Human Services?

Healthcare providers and organizations offering Medicaid services in Nevada must comply with the suspended Medicaid providers list. This includes hospitals, clinics, and individual practitioners. Ensuring compliance is crucial to prevent financial penalties and protect the integrity of Medicaid programs. Non-compliance can lead to loss of funding and damage the reputation of healthcare providers.